DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Kaley TJ, Wen P, Schiff D. , et al.
Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.
Neuro Oncol 2015;
17 (01) 116-121
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.